Mental Health Engagement Network (MHEN)

Not Applicable

Completed

• Conditions: Psychotic Disorder; Mood Disorder
• Interventions: Behavioral: Access to TELUS Health Space and Smart Phone

• Registration Number: NCT01473550
• Lead Sponsor: Lawson Health Research Institute

Brief Summary

Patients with mood disorder or psychotic disorder will be given handheld devices with personal health records to educate, monitor and deliver customizable healthcare tools based on their personal needs. The use of technology has great potential to deliver care more effectively and efficiently. No actual information is on the handheld device - it is accessed from a secure site behind hospital firewalls.

Detailed Description

Not available

Study Timeline

• Study Start: 2011-11
• Study First Submitted: 2011-11-14
• Study First Submitted QC: 2011-11-14
• Study First Posted: 2011-11-17
• Primary Completion: 2014-06
• Study Completion: 2014-06
• Status Verified: 2016-03
• Last Update Submitted: 2016-03-04
• Last Update Posted: 2016-03-07

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 400

Inclusion Criteria

• Must be diagnosed with mood disorder or psychotic disorder for a minimum one year
• Able to make informed consent to participate in the study
• Able to understand and speak English to the degree necessary to participate in interviews/focus groups

Exclusion Criteria

• Younger than 18 or older than 80

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: CROSSOVER

Arm && Interventions

Group	Intervention	Description
Early Intervention	Access to TELUS Health Space and Smart Phone	At Phase 1 (first 3 months of project), the 200 participants in Group 1 will be provided with a Personal Health Record (PHR) through TELUS Health Space, as well as they will be introduced to smart phone technology to ready them for deployment of the prompts and reminders. Two months later, they will be provided with a smart phone.
Later Intervention	Access to TELUS Health Space and Smart Phone	A delayed implementation plan will be used (but will have no effect on the standard of care for the remaining 200 participants), so the remaining 200 participants in Group 2 will initially act as a control group, but at Phase 2 (six months later - approximately June 2012) the remaining 200 participants will be introduced to the technology in the same order (PHR -\> Smart Phone). Group 2 will have the benefit of any enhancements made during Phase 1 of the project.

Primary Outcome Measures

Name	Time	Method
Lehman Quality of Life - Brief Version	Every 6 months for total of 18 months

Trial Locations

Locations (4)

Canadian Mental Health Association (London-Middlesex Branch); 🇨🇦 London, Ontario, Canada

Western Ontario Therapeutic Community Hostel; 🇨🇦 London, Ontario, Canada

Regional Mental Health Care; 🇨🇦 London, Ontario, Canada

London Health Sciences Centre; 🇨🇦 London, Ontario, Canada